TNDM - Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc

TNDM

Tandem Diabetes Care designs and sells insulin delivery technology for diabetes management, including the t:slim X2 and Tandem Mobi insulin pumps. The company also offers related products like cartridges, infusion sets, and data management platforms.

βš•οΈ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago β†’$215today

Score Overview

1 Year
Score
Net Growth69.07%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth2.63%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score3.8
Net Growth-4x
Net Trend40%
Net Income Consistencyβ€”
Rev Growth48.18%
Rev Trend80%
Revenue Consistencyβ€”
10 Years
Score
Net Growth24.13%
Net Trend50%
Net Income Consistency
Rev Growth12x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-0.28%
Net Trend46%
Net Income Consistency
Rev Growth35x
Rev Trend92%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Tandem Diabetes Care Inc has ranked, year by year

Measure
Fundamentals Window

Showing 5 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • TNDM

2019: 69.4% Β· 2021: 46.8% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 16.50β€”
1 Year2025-10-01
$ 12.4132.96%
5 Years2021-10-01
$ 121.18-86.38%
10 Years2016-09-30
$ 76.60-78.46%
All Time2013-11-14
$ 192.60-91.43%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 1.04B-$ 63M$ 455M
2025$ 1.01B-$ 204M$ 292M
2024$ 940M-$ 96M$ 438M
2023$ 747M-$ 222M$ 467M
2022$ 801M-$ 94M$ 616M
2021$ 702M$ 15M$ 623M
2020$ 498M-$ 34M$ 484M
2019$ 362M-$ 24M$ 176M
2018$ 183M-$ 122M$ 129M
2017$ 107M-$ 73M$ 14M
2016$ 84M-$ 83M$ 53M
2015$ 72M-$ 72M$ 71M
2014$ 49M-$ 79M$ 67M
IPO2013$ 29M-$ 63M$ 129M
TNDM - Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 498M to $ 1.01B and net income went from -$ 34M to -$ 204M. Revenue increased in 4 of those 5 years; net income in 2.

Across Tandem Diabetes Care Inc's full reported history, from 2013 to 2025, revenue grew from $ 29M to $ 1.01B and net income went from -$ 63M to -$ 204M. Revenue increased in 92% of the years measured; net income in 46%.

Tandem Diabetes Care Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Continue TNDM’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies